CPT Capital is the venture arm of private equity pioneer Jeremy Coller's private family office. The firm invests in visionary founders creating the future of food and materials. CPT Capital's mission is to drive the food and materials technology revolution by replacing animals in the supply chain. From plant-based protein to recombinant proteins to cell-based meat, CPT backs solutions from pre-seed onwards (ideally getting involved from pre-seed to Series B) with a view to continually backing the company all the way - be that to a sale, an IPO, or longer term. CPT looks for passionate, dynamic founders with a strong vision and desire to be part of the future of protein. It is looking for companies that their product should directly replace an animal-derived product and have a tech or IP-protected element. CPT Capital is open to opportunities across the globe, and are actively looking to expand the geographic representation of its portfolio, which is primarily US-focused at present.